Express News | The USA Food and Drug Administration (FDA): GlaxoSmithKline and Pfizer must issue warnings regarding their respiratory syncytial virus (RSV) vaccines. The RSV vaccines from these two companies may increase the risk of rare neurological side effects.

Breakings06:28

Pfizer Options Spot-On: On January 7th, 183.88K Contracts Were Traded, With 3.21 Million Open Interest

On January 7th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 183.88K options for the day, of which put options accounted for 38.54% of the total transactions, and

Futu News05:30

FDA Requires GSK and Pfizer Vaccines to Carry Rare Side Effect Warnings

Investing05:22

GSK, Pfizer RSV Shots to Warn About Rare Neurological Disorder

BNN Bloomberg04:59

Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies

Seeking Alpha03:58

Express News | Market News: Pfizer executives plan to hold a meeting at Trump's Mar-a-Lago.

Breakings01:13